{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:21:38Z","timestamp":1795206098663,"version":"4.10.3"},"reference-count":48,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12,1]]},"abstract":"<jats:p>Insulin resistance is conventionally framed as a pathological defect in insulin action that contributes to type 2 diabetes and related metabolic disease and should therefore be identified and reversed. The comprehensive review by Gastaldelli and colleagues highlights a more complicated reality: insulin resistance is heterogeneous between individuals, tissues, pathways, and physiological states. I argue that this heterogeneity exposes a fundamental issue\u2014insulin resistance is a phenotype, not a mechanism. It can arise through many molecular routes, occur in both disease and normal physiology, originate in different tissues, and long precede overt disease. I propose an \u201cinsulin resistance mosaic\u201d in which its clinical significance depends on why and where insulin resistance develops, physiological compensation, environmental exposure, and end-organ vulnerability. Similar degrees of insulin resistance could therefore lead to very different clinical outcomes, remain compensated for decades, or even, in some contexts, be protective. This framework challenges the assumption that insulin resistance represents a single disease process that should invariably be overcome. Instead, we should determine why it has developed, where it resides, what it predicts, and whether modifying it improves clinical outcomes.<\/jats:p>","DOI":"10.2337\/dbi26-0047","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:01:45Z","timestamp":1790596905000},"page":"2166-2171","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["The Insulin Resistance Mosaic: Defect, Defense, or Both? A Perspective on What Insulin Resistance Means and Whether It Should be Treated"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5946-5257","authenticated-orcid":false,"given":"David E.","family":"James","sequence":"first","affiliation":[{"name":"Charles Perkins Centre, School of Life and Environmental Science, School of Medical Science, The University of Sydney 1 , New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026112014572430100_B1","doi-asserted-by":"crossref","DOI":"10.2337\/dbi26-0044","article-title":"Insulin resistance in the 21st century: new takes on an old problem\u20142025 Diabetes, Diabetes Care, and Diabetologia Expert Forum","author":"Gastaldelli","year":"2026","journal-title":"Diabetes"},{"key":"2026112014572430100_B2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/ije\/dyt203","article-title":"Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. 1936","volume":"42","author":"Himsworth","year":"2013","journal-title":"Int J Epidemiol"},{"key":"2026112014572430100_B3","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0026-0495(78)80007-9","article-title":"Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction","volume":"27","author":"Kahn","year":"1978","journal-title":"Metabolism"},{"key":"2026112014572430100_B4","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.2337\/db11-0425","article-title":"Fatty acids, obesity, and insulin resistance: time for a reevaluation","volume":"60","author":"Karpe","year":"2011","journal-title":"Diabetes"},{"key":"2026112014572430100_B5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"2026112014572430100_B6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2337\/dc20-1644","article-title":"Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease","volume":"44","author":"Ter Horst","year":"2021","journal-title":"Diabetes Care"},{"key":"2026112014572430100_B7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-015-3751-0","article-title":"Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis","volume":"59","author":"Abdulla","year":"2016","journal-title":"Diabetologia"},{"key":"2026112014572430100_B8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0950-351X(96)80330-2","article-title":"Mutant insulin receptors in syndromes of insulin resistance","volume":"10","author":"Krook","year":"1996","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"2026112014572430100_B9","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1172\/JCI84005","article-title":"PI3-kinase mutation linked to insulin and growth factor resistance in vivo","volume":"126","author":"Winnay","year":"2016","journal-title":"J Clin Invest"},{"key":"2026112014572430100_B10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1172\/JCI7961","article-title":"Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice","volume":"104","author":"Wojtaszewski","year":"1999","journal-title":"J Clin Invest"},{"key":"2026112014572430100_B11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI7917","article-title":"Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2","volume":"105","author":"Kido","year":"2000","journal-title":"J Clin Invest"},{"key":"2026112014572430100_B12","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.cmet.2024.10.020","article-title":"Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action","volume":"36","author":"Needham","year":"2024","journal-title":"Cell Metab"},{"key":"2026112014572430100_B13","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1016\/j.cell.2025.05.005","article-title":"Personalized molecular signatures of insulin resistance and type 2 diabetes","volume":"188","author":"Kj\u00e6rgaard","year":"2025","journal-title":"Cell"},{"key":"2026112014572430100_B14","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1194\/jlr.R087510","article-title":"Muscle and adipose tissue insulin resistance: malady without mechanism?","volume":"60","author":"Fazakerley","year":"2019","journal-title":"J Lipid Res"},{"key":"2026112014572430100_B15","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1074\/jbc.M111.318238","article-title":"Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes","volume":"287","author":"Tan","year":"2012","journal-title":"J Biol Chem"},{"key":"2026112014572430100_B16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nature13425","article-title":"A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes","volume":"512","author":"Moltke","year":"2014","journal-title":"Nature"},{"key":"2026112014572430100_B17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jcem-64-6-1169","article-title":"Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance","volume":"64","author":"Hollenbeck","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2026112014572430100_B18","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00125-008-1025-9","article-title":"Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?","volume":"51","author":"Florez","year":"2008","journal-title":"Diabetologia"},{"key":"2026112014572430100_B19","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"key":"2026112014572430100_B20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"key":"2026112014572430100_B21","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"key":"2026112014572430100_B22","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s42255-024-01153-1","article-title":"Skeletal muscle from TBC1D4 p.Arg684Ter variant carriers is severely insulin resistant but exhibits normal metabolic responses during exercise","volume":"6","author":"Kristensen","year":"2024","journal-title":"Nat Metab"},{"key":"2026112014572430100_B23","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1210\/jc.2015-2712","article-title":"Phenotypic characterization of insulin-resistant and insulin-sensitive obesity","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2026112014572430100_B24","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41366-020-0565-z","article-title":"Metabolic profiling of tissue-specific insulin resistance in human obesity: results from the Diogenes study and the Maastricht Study","volume":"44","author":"Vogelzangs","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"2026112014572430100_B25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12933-024-02188-0","article-title":"Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study","volume":"23","author":"Gijbels","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026112014572430100_B26","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","article-title":"Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects","volume":"50","author":"Boden","year":"2001","journal-title":"Diabetes"},{"key":"2026112014572430100_B27","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/db10-0162","article-title":"Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans","volume":"59","author":"Tam","year":"2010","journal-title":"Diabetes"},{"key":"2026112014572430100_B28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cmet.2012.12.007","article-title":"Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice","volume":"17","author":"Parks","year":"2013","journal-title":"Cell Metab"},{"key":"2026112014572430100_B29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00360-016-1050-9","article-title":"Life in the fat lane: seasonal regulation of insulin sensitivity, food intake, and adipose biology in brown bears","volume":"187","author":"Rigano","year":"2017","journal-title":"J Comp Physiol B"},{"key":"2026112014572430100_B30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"22","author":"James","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026112014572430100_B31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cmet.2026.06.012","article-title":"Insulin resistance and type 2 diabetes as allostatic responses to chronic nutrient excess","volume":"38","author":"Prentki","year":"2026","journal-title":"Cell Metab"},{"key":"2026112014572430100_B32","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.2337\/db12-1179","article-title":"Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans","volume":"62","author":"Nowotny","year":"2013","journal-title":"Diabetes"},{"key":"2026112014572430100_B33","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.2337\/db12-0108","article-title":"Lipid-induced insulin resistance is not mediated by impaired transcapillary transport of insulin and glucose in humans","volume":"61","author":"Szendroedi","year":"2012","journal-title":"Diabetes"},{"key":"2026112014572430100_B34","doi-asserted-by":"crossref","first-page":"eadq4461","DOI":"10.1126\/sciadv.adq4461","article-title":"Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans","volume":"10","author":"Fiorenza","year":"2024","journal-title":"Sci Adv"},{"key":"2026112014572430100_B35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/diab.44.7.837","article-title":"Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma","volume":"44","author":"Battezzati","year":"1995","journal-title":"Diabetes"},{"key":"2026112014572430100_B36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.510280119","article-title":"Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity","volume":"28","author":"Petrides","year":"1998","journal-title":"Hepatology"},{"key":"2026112014572430100_B37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/diacare.24.4.710","article-title":"Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone","volume":"24","author":"Miyazaki","year":"2001","journal-title":"Diabetes Care"},{"key":"2026112014572430100_B38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"key":"2026112014572430100_B39","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1262-3636(14)72689-8","article-title":"Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: a review of the clinical evidence","volume":"40","author":"Scheen","year":"2014","journal-title":"Diabetes Metab"},{"key":"2026112014572430100_B40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1152\/japplphysiol.00123.2005","article-title":"Exercise-induced increase in muscle insulin sensitivity","volume":"99","author":"Holloszy","year":"2005","journal-title":"J Appl Physiol (1985)"},{"key":"2026112014572430100_B41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ajcn\/55.2.356","article-title":"Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals","volume":"55","author":"Franssila-Kallunki","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"2026112014572430100_B42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/oby.2009.380","article-title":"Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue","volume":"18","author":"McLaughlin","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"2026112014572430100_B43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jne.12254","article-title":"Insulin action in the human brain: evidence from neuroimaging studies","volume":"27","author":"Kullmann","year":"2015","journal-title":"J Neuroendocrinol"},{"key":"2026112014572430100_B44","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1038\/s41467-020-15686-y","article-title":"Brain insulin sensitivity is linked to adiposity and body fat distribution","volume":"11","author":"Kullmann","year":"2020","journal-title":"Nat Commun"},{"key":"2026112014572430100_B45","doi-asserted-by":"crossref","first-page":"e12934","DOI":"10.1111\/jne.12934","article-title":"Intranasal insulin","volume":"33","author":"Hallschmid","year":"2021","journal-title":"J Neuroendocrinol"},{"key":"2026112014572430100_B46","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2337\/db11-1390","article-title":"Postprandial administration of intranasal insulin intensifies satiety and reduces intake of palatable snacks in women","volume":"61","author":"Hallschmid","year":"2012","journal-title":"Diabetes"},{"key":"2026112014572430100_B47","doi-asserted-by":"crossref","first-page":"eabf4100","DOI":"10.1126\/sciadv.abf4100","article-title":"Insulin signaling in AgRP neurons regulates meal size to limit glucose excursions and insulin resistance","volume":"7","author":"Dodd","year":"2021","journal-title":"Sci Adv"},{"key":"2026112014572430100_B48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/s41586-024-07922-y","article-title":"Pathogenic hypothalamic extracellular matrix promotes metabolic disease","volume":"633","author":"Beddows","year":"2024","journal-title":"Nature"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/12\/2166\/896204\/dbi260047.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/12\/2166\/896204\/dbi260047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:57:30Z","timestamp":1795204650000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/12\/2166\/172562\/The-Insulin-Resistance-Mosaic-Defect-Defense-or"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,9,28]]},"published-print":{"date-parts":[[2026,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dbi26-0047","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}